US$ 20.05
compounded semaglutide hers Hims & Expands Personalized Weight Loss Portfolio with Access to Pills Starting at $49/Month* Novo Nordisk Shares Rise, Hims
Description
The popular drug has been linked to a number of health concerns, including eye problems

Victoza (liraglutide) [package insert]

"Procurement Strategies for Novel Therapeutic APIs: Risk Management and Supplier Evaluation." Pharmaceutical Procurement Management, 2024.

oral formulation (Rybelsus) also available Lixisenatide (Lyxumia) once-daily injection NICE guidance for type 2 diabetes (NG28) recommends GLP-1 receptor agonists in specific circumstances: typically as a third-line option when other treatments haven't achieved adequate glycaemic control, particularly in people with a BMI 35 kg/m (adjusted for ethnicity), or for whom weight loss would benefit other obesity-related comorbidities, or for whom insulin would have significant occupational implications

For many, losing weight and keeping it off feels like an uphill battle, making science-backed options all the more crucial
